Search For
/
Stocks
Intraday Booster
Sector Booster
Stock Screener
Market Pulse
Screeners
More
Go Prime
My Plans
Privacy Policy
Contact
Refer & EarnScreenersMain
Stock Screener
Create Screener
Explore Screeners
Community ScreenersTrading Screeners
CandleSticks Screener
Top Gainers & Losers
Opening Range Breakout
Stock Screener AI
Stock Quality Scorecard
Overvalued StocksNewUndervalued StocksNewTechnical Screeners
NR4 Stocks
NR7 Stocks
Previous Day High Breakout
Previous Day Low Breakout
Previous Day Open Breakout
Bullish Crossover Stocks
Bearish Crossover Stocks
High Volume Shocker
VWAP Breakout Stocks
Range High Breakout
Range Low BreakoutMoreMarkets
Global Market Today
Global Indices
Indian Indices
NIfty TodaySmart Money
FII DII DataNew
FII Buying
NSE Insider Trading
SLB Stocks DataDerivatives
FnO Movements
NSE F&O Lot Size
Ban ListAnalysis & Calendars
Technical DashboardSector Booster
Sector AnalysisNew
Result Calendar
Economic Calendar
India Glycols
Mid Cap•1,326 Employees•IPO 1994
Current Price
₹854.60
-25.65 (-2.91%)Updated
Valuation vs Sector
P/E Ratio
20.35vs 34.76
P/B Ratio
2.25vs 8.63
Div Yield
0.01%vs 1.71%
Today's Range
850
₹854.60
884.7
52 Week Range
52W Low₹792.50
52W High₹2138.00
₹854.60
Downside7.84%
Upside150.18%
Price Chart
Compare with Peers
Historical Ratios
Track top 12 most important financial ratios
P/E Ratio: Price to Earnings - Most used valuation metric
Loading chart...
Analyzing Investment Quality
Processing 9 key metrics...
Key Metrics
Hover for details
Valuation
Market Cap
₹6,432.89 Cr
Market Cap
Total market value of companyP/E Ratio
24.82
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)P/B Ratio
2.22
P/B Ratio
Price to Book Value. <3 may indicate undervaluationEPS
₹41.85
EPS
Earnings Per Share. Higher and growing is positiveProfitability
ROE
5.55%
ROE
Return on Equity. >15% is good, >20% is excellentROCE
12.40%
ROCE
Return on Capital Employed. >15% is goodNet Margin
2.72%
Net Margin
Net profit as % of revenue. >10% is goodOperating Margin
-%
Operating Margin
Operating profit margin. >15% is goodGrowth
EPS Growth (5Y)
0.16%
EPS Growth (5Y)
5-year EPS growth. >15% is strongRevenue Growth (5Y)
11.62%
Revenue Growth (5Y)
5-year revenue growth. >10% is goodQtr Sales Growth
7.41%
Qtr Sales Growth
Quarter-over-quarter sales growthQtr Profit Growth
21.30%
Qtr Profit Growth
Quarter-over-quarter profit growthFinancial Health
Debt/Equity
0.84
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellentBook Value
₹364.30
Book Value
Net asset value per shareDividend Yield
0.01%
Dividend Yield
Annual dividend as % of price. >2% is goodPromoter Holding
61.00%
Promoter Holding
Promoter stake. >50% shows confidenceGood
Average
Needs Attention
SWOT Analysis
Strengths
4 points- •India Glycols Ltd boasts a strong promoter holding of 61%, indicating significant management confidence in the company's future prospects and stability. This high stake reduces risks related to corporate governance and strategic direction.
- •The company demonstrates a healthy Return on Equity (ROE) of 11.10%, reflecting efficient capital utilization. This is further supported by a robust 21.30% quarterly profit variation, signaling strong profitability.
Weaknesses
4 points- •India Glycols Ltd carries a notable debt-to-equity ratio of 0.84, implying significant reliance on debt financing. This elevated debt level could increase financial risk and vulnerability during economic downturns.
- •The company's stock has shown recent volatility, with a -1.15% change on Oct 30 and a -0.85% change on Oct 28, following a 1.71% rise on Oct 27. This fluctuation presents a risk for stability-seeking investors.
Opportunities
3 points- •Operating in the 'Breweries & Distilleries' and 'Fast Moving Consumer Goods' sectors, India Glycols can capitalize on rising disposable incomes and evolving consumer preferences, driving demand for its products.
- •Potential for geographical expansion into new markets or diversification within the broader Fast Moving Consumer Goods sector could unlock significant growth avenues and enhance revenue streams for the company.
Threats
4 points- •The company faces intense competition from larger, well-established players in the 'Breweries & Distilleries' sector, such as United Spirits and UBL, which could pressure market share and profit margins.
- •The 'Breweries & Distilleries' industry is subject to stringent regulatory changes, including taxation and licensing policies, which could negatively impact operations and profitability for India Glycols.
Segment-wise Financial Analysis
Fetching Financials...
Fetching Balance Sheet...
Fetching Cash Flow...
Shareholding Pattern
Loading shareholding data...
Company Insider Trading Activity
No insider trading data available
Corporate Action
Company Announcements
Technical Analysis & Indicators
Standard pivot points - most widely used
Pivot Points (CLASSIC)
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹945.60 | +₹91.00 | +10.65% |
| R3 | ₹910.90 | +₹56.30 | +6.59% |
| R2 | ₹897.80 | +₹43.20 | +5.05% |
| R1 | ₹876.20 | +₹21.60 | +2.53% |
| PIVOT | ₹863.10 | 8.50 | 0.99% |
| CURRENT | ₹854.60 | - | - |
| S1 | ₹772.10 | -₹82.50 | -9.65% |
| S2 | ₹806.80 | -₹47.80 | -5.59% |
| S3 | ₹828.40 | -₹26.20 | -3.07% |
| S4 | ₹841.50 | -₹13.10 | -1.53% |
CPR Levels
Support
Resistance
S4
N/A
S3
N/A
S2
N/A
S1
N/A
| CPR |
BC: N/AP: N/ATC: N/A
R1
N/A
R2
N/A
R3
N/A
R4
N/A
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment
is trading CPR, indicating
● CPR Width
CPR is
● Opening Range
Day's range: ~
● Price Position
Trading Inside opening range
Delivery Volume Analysis & Trading Activity
Latest Volume-3.9% vs avg
0.88L
(13 Mar 2026)Delivery %+6.9% vs avg
53.1%
(13 Mar 2026)Avg Volume (20D)20-day average
0.92L
(13 Feb - 13 Mar)Avg Delivery %Trend ↑
46.2%
(13 Feb - 13 Mar)Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.
Peer Comparison & Industry Benchmarking
Quick Compare
Largest by Market Cap
Solar Industries India Ltd
1.20L ₹ Cr
Best Profit Growth
Rain Industries Ltd
178.00 %
Highest Dividend Yield
Gujarat Narmada Valley Fertilizers & Chemicals Ltd
3.88 %
Peer Comparison
| Company Name |
|---|
 Carborundum Universal Ltd |
 Epigral Ltd |
 Finolex Industries Ltd |
 GHCL Ltd |
 Gujarat Narmada Valley Fertilizers & Chemicals Ltd |
 Garware Hi Tech Films Ltd |
 Gulf Oil Lubricants India Ltd |
 Kingfa Science & Technology (India) Ltd |
 PCBL Chemical Ltd |
 Rain Industries Ltd |
 Responsive Industries Ltd |
 Solar Industries India Ltd |
 Styrenix Performance Materials Ltd |
About
India Glycols Ltd
India Glycols Limited (IGL) is an Indian green petrochemical company primarily involved in the manufacturing and sale of a diverse range of industrial chemicals. Their business operations are segmented into three key areas: Bio-based Specialities and Performance Chemicals, Potable Spirits, and Ennature Biopharma. This diversified approach allows them to cater to a wide array of industrial and consumer needs.
The Bio-based Specialities and Performance Chemicals segment forms a significant portion of IGL's business. Here, they produce and market a broad spectrum of products, including various glycols (mono, di, and tri ethylene glycols), glycol ethers and acetates used in brake fluids, bio-polymers derived from guar and natural gums, and a selection of specialty chemicals. These specialty chemicals encompass a wide range of applications, from plasticisers and oil field chemicals to bio-amines, methyl soyate, MDEA and its derivatives, bio-potash granules, and their proprietary C-Smart specialty products. This segment highlights IGL's commitment to sustainable and bio-based alternatives within the chemical industry.
IGL's Potable Spirits segment focuses on the production and distribution of alcoholic beverages. Their brand portfolio includes a variety of whiskeys (Soulmate Blu and Single Reserve), vodka (Amazing), rum (Zumba and Beach House XXX), and economy spirits (Bunty), along with branded country liquor. This segment demonstrates IGL's expansion into the consumer goods market, leveraging their production capabilities to offer a selection of alcoholic drinks.
Finally, the Ennature Biopharma segment caters to the pharmaceutical and healthcare sectors. IGL produces natural active pharmaceutical ingredients (APIs), nutraceuticals, standardized botanical extracts, and nicotine derivatives. This segment underscores IGL's commitment to providing high-quality ingredients for the healthcare industry, complementing their offerings in other sectors.
In summary, India Glycols Limited operates across multiple sectors, showcasing a diversified business model. Their products find application in a vast array of industries including pharmaceuticals, textiles, automotive, personal care, industrial manufacturing, paints and coatings, oil and gas, food ingredients, packaging, and the spirits industry. Furthermore, IGL actively participates in the export market, distributing their products internationally.
COMPANY FACTS - INDIAGLYCO
Registered Address
2B, Sector-126, Noida, Gautam Budh Nagar
Noida
UTTAR PRADESH
IN
Tel: 911206860000
Website:https://www.indiaglycols.com/
Investor Relations:http://www.indiaglycols.com/investors/investor_index.htm
Company Details
Group: Materials
Sector: Materials
Industry: Chemicals
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 1,326
IPO Date: 28/12/1994
MANAGEMENT - INDIAGLYCO
Shri. Uma Bhartia
Executive Chairman of the Board, Managing Director
Shri. Rupark Sarswat
Chief Executive Officer
Shri. Anand Singhal
Chief Financial Officer
Shri. Ankur Jain
Compliance Officer, Company Secretary, Head - Legal
Ms. Pragya Barwale
Whole-Time Director
Shri. Alok Singhal
Executive Director
Smt. Jayshree Bhartia
Promoter Director
Shri. Samrat Banerjee
Additional Non-Executive Independent Director
Mr. Ravi Kumar
Non-Executive Independent Director
Shri. Sushil Salwan
Additional Non-Executive Independent Director
Smt. Shukla Wassan
Non-Executive Independent Director
Investor Questions Answered
India Glycols Ltd (INDIAGLYCO) Stock FAQs
Get answers to the most common questions about India Glycols Ltd stock price, fundamentals, financial metrics, and investment analysis
The current share price of India Glycols Ltd (INDIAGLYCO) is ₹854.6. Today, the stock has declined by ₹25.65 (2.91%), trading in a range of ₹850 to ₹884.7. The stock opened at ₹884.7 with a trading volume of 88,126 shares.
India Glycols Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹6,432.89 crores, P/E ratio of 24.82, ROE of 5.55%, and ROCE of 12.40%. The dividend yield stands at 0.01%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of India Glycols Ltd (INDIAGLYCO) is ₹2,138, while the 52-week low is ₹792.5. Currently trading at ₹854.6, the stock is 4.6% away from its 52-week low and 60.0% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy India Glycols Ltd stock at ₹854.6 depends on multiple factors. The stock is currently trading with a P/E ratio of 24.82 and P/B ratio of N/A. Today's performance shows a loss of 2.91%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
India Glycols Ltd offers a dividend yield of 0.01%, which means for every ₹100 invested at the current price of ₹854.6, you can expect to receive approximately ₹0.01 annually as dividends. The face value of the stock is ₹5.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
India Glycols Ltd's key financial metrics include: P/E Ratio: 24.82, P/B Ratio: N/A, ROE: 5.55%, ROCE: 12.40%, Dividend Yield: 0.01%, EPS: ₹41.85, Book Value: ₹364.3, Debt-to-Equity: 0.84, and Current Ratio: N/A. The company's market cap stands at ₹6,432.89 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
India Glycols Ltd stock opened at ₹884.7 and is currently trading at ₹854.6, showing a decline of ₹25.65 (2.91%). The intraday high is ₹884.7 and low is ₹850. The trading volume stands at 88,126 shares, indicating moderate market participation today.
India Glycols Ltd has a Price-to-Earnings (P/E) ratio of 24.82, which means investors are willing to pay ₹24.82 for every ₹1 of earnings. With an EPS of ₹41.85, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
India Glycols Ltd has a market capitalization of ₹6,432.89 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹854.6) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
India Glycols Ltd has a book value of ₹364.3 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹854.6, which is 134.6% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
India Glycols Ltd has a Return on Equity (ROE) of 5.55% and Return on Capital Employed (ROCE) of 12.40%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
India Glycols Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
India Glycols Ltd has a debt-to-equity ratio of 0.84, which measures the company's financial leverage by comparing total debt to shareholders' equity. This moderate ratio indicates balanced use of debt and equity. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
India Glycols Ltd has an Earnings Per Share (EPS) of ₹41.85, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹854.6 and P/E ratio of 24.82, investors are paying 24.82 times the annual earnings per share. This moderate EPS suggests decent earnings generation. Track EPS growth over quarters to assess earnings momentum.
India Glycols Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
India Glycols Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze India Glycols Ltd stock, consider: 1) Fundamental Analysis - Review P/E (24.82), ROE (5.55%), debt-to-equity (0.84), and growth rates. 2) Technical Analysis - Check 52-week range (₹792.50 - ₹2138.00), moving averages, and chart patterns. 3) Valuation - Compare current price (₹854.60) with book value (₹364.30) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of India Glycols Ltd share is ₹5.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹854.6 is 16992x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in India Glycols Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹792.50 - ₹2138.00). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.84 indicates leverage. 4) Liquidity Risk - Based on trading volume of 88,126 shares. 5) Valuation Risk - P/E of 24.82 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
India Glycols Ltd operates in the industry with key metrics: P/E ratio of 24.82, ROE of 5.55%, market cap of ₹6,432.89 crores, and dividend yield of 0.01%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.84), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for India Glycols Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹854.6, with a 52-week range of ₹792.50 to ₹2138.00. Based on fundamentals like P/E (24.82), ROE (5.55%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling India Glycols Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹854.60. 2) Fundamental Deterioration - Declining ROE (currently 5.55%), increasing debt (D/E: 0.84), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for India Glycols Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.01%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.
Menu